Skip to main content

Table 1 Characteristics of the study subjects

From: Influences of changes in obesity-related parameters on progression of arteriosclerosis in hemodialysis patients: a prospective cohort study

Number of patients

258

Age (years)

67.4 ± 12.1

Gender (m/f)

146/112

Body mass index (kg/m2)

22.2 ± 3.7

Dialysis history (months)

63.2 ± 55.4

Diabetes (%)

123 (47.7)

Hyperlipidemia drugs (%)

35 (13.6)

Systolic BP (mmHg)

152 ± 22

Diastolic BP (mmHg)

76 ± 14

Laboratory study

 Hemoglobin (g/dl)

10.8 ± 1.0

 High-density lipoprotein cholesterol (mg/dl)

46.8 ± 14.6

 Low-density lipoprotein cholesterol (mg/dl)

88.7 ± 29.4

 Triglyceride (mg/dl)

103.2 ± 65.5

 Uric acid (mg/dl)

7.2 ± 1.3

 Creatinine (mg/dl)

9.6 ± 2.5

 C-reactive protein (mg/dl)

0.34 ± 0.70

 Ca (mg/dl)

8.9 ± 0.5

 Inorganic phosphorus (mg/dl)

5.2 ± 1.2

 Intact-parathyroid hormone (pg/ml)

143.4 ± 85.0

 Albumin (g/dl)

3.7 ± 0.3

 Hemoglobin A1c (%)

5.34 ± 0.85

 Human atrial natriuretic polypeptide (pg/ml)

69.3 ± 107.9

 Brain natriuretic peptide (pg/ml)

264.5 ± 404.1

Cardiothoracic ratio (%)

52.3 ± 5.3

Brachial-ankle pulse wave velocity (cm/s)

2041 ± 654

Abdominal circumference (cm)

83.5 ± 10.3

Visceral fat area (cm2)

84.7 ± 59.2

Subcutaneous fat area (cm2)

118.2 ± 73.0

  1. Values are expressed as mean ± SD